Insulin detemir Subcutaneous and Pramipexole Extended-Release Tablets
Determining the interaction of Insulin detemir Subcutaneous and Pramipexole Extended-Release Tablets and the possibility of their joint administration.
No interaction was detected between the selected drugs or effects of joint drug administration are currently understudied, and it takes time and accumulated statistics to determine their interaction. A doctor should be consulted to address the issue of joint drug administration.
Generic Name: insulin detemir
Brand name: Levemir, Levemir FlexPen, Levemir PenFill, Levemir InnoLet, Levemir FlexTouch
Synonyms: Insulin detemir, Insulin Detemir
Generic Name: pramipexole
Brand name: Mirapex, Mirapex ER
Synonyms: Pramipexole
In the course of checking the drug compatibility and interactions, data from the following reference sources was used: Drugs.com, Rxlist.com, Webmd.com, Medscape.com.
- Insulin detemir Subcutaneous-Pramipexole Tablets
- Insulin detemir Subcutaneous-Pramlintide
- Insulin detemir Subcutaneous-Pramlintide Acetate
- Insulin detemir Subcutaneous-Pramlintide Subcutaneous
- Insulin detemir Subcutaneous-Pramosone
- Insulin detemir Subcutaneous-Pramosone Cream
- Pramipexole Extended-Release Tablets-Insulin glargine
- Pramipexole Extended-Release Tablets-Insulin Glargine (U-100) Cartridge Systems and Pens
- Pramipexole Extended-Release Tablets-Insulin Glargine (U-100) Vials
- Pramipexole Extended-Release Tablets-Insulin Glargine (U-300) Pens
- Pramipexole Extended-Release Tablets-Insulin glargine and lixisenatide
- Pramipexole Extended-Release Tablets-Insulin glargine and lixisenatide Subcutaneous